Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...

In a move aimed at expanding affordable treatment options for millions of Americans living with diabetes, Biocon Biologics Ltd. and nonprofit generic drug manufacturer Civica, Inc. have announced a ...

Clinicians are increasingly prescribing GLP-1 receptor agonists, metformin, and SGLT-2 inhibitors—drugs approved for type 2 diabetes—to people with type 1 diabetes to improve weight, blood sugar ...

California has partnered with nonprofit drugmaker Civica to produce low-cost versions of insulin under the state's own label, notwithstanding recent price reductions announced by leading manufacturers ...

The updated labeling provides a new conversion chart for starting dosages when switching patients from subcutaneous mealtime insulin to Afrezza. The Food and Administration (FDA) has approved updated ...

BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...